Using these antigens, researchers plan to develop vaccine candidates that they hope would stimulate a strong immune response against the world’s deadliest pathogen.

Co-founded by Kanav Setia and Jason Necaise ’20, qBraid lets users access the most popular quantum devices and software programs on an intuitive, cloud-based platform.

MIT engineers developed a programmable drug-delivery patch that can promote tissue healing and blood vessel regrowth following a heart attack.

The KATMAP model, developed by researchers in the Department of Biology, can predict alternative cell splicing, which allows cells to create endless diversity from the same sets of genetic blueprints.

MIT researchers show they can use messenger RNA to activate the pathway and trigger the immune system to attack tumors.

Targeted particles carrying the cytokine IL-12 can jump-start T cells, allowing them to clear tumors while avoiding side effects.

The technology would allow battery-free, minimally invasive, scalable bioelectronic implants such as pacemakers, neuromodulators, and body process monitors.

Selective crystallization can greatly improve the purity, selectivity, and active yield of viral vector-based gene therapy drugs, MIT study finds.

Adding amino acids to certain protein-based medications can improve stability and effectiveness. New MIT research demonstrates how it works.